# KRTAP5-10

## Overview
KRTAP5-10, or keratin associated protein 5-10, is a gene that encodes a protein belonging to the keratin-associated protein family, which is integral to the structural composition of hair and nails. The protein encoded by KRTAP5-10 is primarily involved in the formation and maintenance of hair fibers, where it interacts with keratin intermediate filaments to enhance mechanical strength and resilience. This interaction is crucial for the elasticity and tensile strength of hair, as it forms a matrix around keratin filaments, contributing to the structural integrity of hair fibers. The gene's expression and the protein's function are significant in the context of hair health and appearance, as well as in certain pathological conditions where alterations in KRTAP5-10 expression have been observed (Qin2022Identification; Isa2022The; Chen2020The).

## Function
KRTAP5-10 (keratin associated protein 5-10) is a member of the keratin-associated protein family, which plays a crucial role in the structure and function of hair and nails. These proteins interact with keratin intermediate filaments to provide mechanical strength and resilience. KRTAP5-10 is primarily active in the hair cortex, contributing to hair fiber formation and integrity. The protein is involved in the molecular processes that ensure the mechanical properties of hair, such as elasticity and tensile strength, by forming a matrix around keratin filaments. This interaction is essential for maintaining the structural integrity of hair fibers, allowing them to withstand physical stress and environmental factors. The presence of KRTAP5-10 in the hair cortex highlights its role in the development and maintenance of hair, impacting the overall health and appearance of hair in humans. The protein's function is critical for the proper assembly and stabilization of keratin filaments, which are vital for the protective and aesthetic functions of hair and nails. The specific molecular activities of KRTAP5-10 include binding to keratin filaments and participating in the formation of disulfide bonds, which are crucial for the cross-linking and stabilization of the hair shaft.

## Clinical Significance
KRTAP5-10 has been implicated in several diseases and conditions through alterations in its expression levels and interactions. In head and neck squamous cell carcinoma (HNSCC), the presence of Fusobacterium nucleatum is associated with hypomethylation of the KRTAP5-10 promoter region, leading to increased expression of the gene. This alteration suggests a potential role for KRTAP5-10 in the progression of HNSCC, as the bacterium may act as a 'driver' in early cancer development by influencing gene expression through epigenetic changes (Chen2020The).

In multiple myeloma, KRTAP5-10 is part of a cluster of genes that show significant downregulation when treated with a combination of RSK2 and AKT inhibitors. This downregulation is more pronounced compared to treatment with either agent alone, indicating that KRTAP5-10 may be involved in pathways affected by these treatments, although its specific clinical significance in this context is not detailed (Isa2022The).

In recurrent bladder cancer, KRTAP5-10, along with KRTAP5-8 and KRTAP5-9, is down-regulated and enriched in certain cellular components. This downregulation may be associated with changes in the intermediate filament cytoskeleton, which is relevant to the disease's pathology (Qin2022Identification).

## Interactions



## References


[1. (Qin2022Identification) Jia-Xin Qin, Xing Liu, Xin-Lei Wang, Guang-Yue Wang, Qing Liang, Yang Dong, Kun Pang, Lin Hao, Liang Xue, Yan Zhao, Zheng-Xiang Hu, Rui Li, Qian Lv, Liu Chao, Fan-Lai Meng, Zhen-Duo Shi, and Cong-Hui Han. Identification and analysis of microrna editing events in recurrent bladder cancer based on rna sequencing: microrna editing level is a potential novel biomarker. Frontiers in Genetics, September 2022. URL: http://dx.doi.org/10.3389/fgene.2022.984279, doi:10.3389/fgene.2022.984279. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.984279)

[2. (Isa2022The) Reiko Isa, Mano Horinaka, Taku Tsukamoto, Kentaro Mizuhara, Yuto Fujibayashi, Yoko Taminishi-Katsuragawa, Haruya Okamoto, Shusuke Yasuda, Yuka Kawaji-Kanayama, Yayoi Matsumura-Kimoto, Shinsuke Mizutani, Yuji Shimura, Masafumi Taniwaki, Toshiyuki Sakai, and Junya Kuroda. The rationale for the dual-targeting therapy for rsk2 and akt in multiple myeloma. International Journal of Molecular Sciences, 23(6):2919, March 2022. URL: http://dx.doi.org/10.3390/ijms23062919, doi:10.3390/ijms23062919. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23062919)

[3. (Chen2020The) Zigui Chen, Po Yee Wong, Cherrie W. K. Ng, Linlin Lan, Sherwood Fung, Jing W. Li, Liuyang Cai, Pu Lei, Qianqian Mou, Sunny H. Wong, William K. K. Wu, Ryan J. Li, Katie Meehan, Vivian W. Y. Lui, Chit Chow, Kwok W. Lo, Amy B. W. Chan, Siaw Shi Boon, Eric H. L. Lau, Zenon Yeung, Kwan C. Allen Chan, Eddy W. Y. Wong, Alfred S. L. Cheng, Jun Yu, Paul K. S. Chan, and Jason Y. K. Chan. The intersection between oral microbiota, host gene methylation and patient outcomes in head and neck squamous cell carcinoma. Cancers, 12(11):3425, November 2020. URL: http://dx.doi.org/10.3390/cancers12113425, doi:10.3390/cancers12113425. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers12113425)